• Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 11 Mar 2025 01:41:14   America/Chicago


    Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat March 11, 2025 Share Link copied to clipboard. Remove Ads Enanta Pharmaceuticals, Inc.
    Read more...
Share on,